Brief: US FDA Approves Arcutis' Zoryve To Treat Atopic Dermatitis In Patients 6 Years Of Age And Older

Arcutis Biotherapeutics

09/07/2024 23:22

July 9 (Reuters) - Arcutis Biotherapeutics Inc  ARQT.O :
    * FDA APPROVES ARCUTIS’ ZORYVE® (ROFLUMILAST) CREAM 0.15%
FOR THE
TREATMENT OF ATOPIC DERMATITIS IN ADULTS AND CHILDREN DOWN TO 6
YEARS OF AGE
    * ARCUTIS BIOTHERAPEUTICS INC - COMMERCIAL PRODUCT EXPECTED
TO BE
AVAILABLE BY END OF JULY

Source text for Eikon:  ID:nGNX3xFXRF 
Further company coverage:  ARQT.O 

 ((Reuters.Briefs@thomsonreuters.com;))